The company's liquidity position has tightened, with the current ratio declining to 0.92 in 2026Q1, while the balance sheet remains heavily weighted toward $2.6B in goodwill.
| Total Current Assets | 687.48M | 728.9M | 755.79M | 649.02M | 585.31M | 670.06M | 363.25M | 181.41M | 1.11M | 119.82K |
| Cash & Short-Term Investments | 47.96M | 106.14M | 109.75M | 77.13M | 46.27M | 149.63M | 99.96M | 76.88M | 947.1K | 119.82K |
| Cash Only | 47.96M | 106.14M | 109.75M | 77.13M | 46.27M | 149.63M | 99.96M | 76.88M | 947.1K | 119.82K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 391.97M | 370.9M | 408.02M | 388.91M | 359.15M | 359.9M | 171.06M | 78.62M | 53.02M | 0 |
| Days Sales Outstanding | 50.05 | 41.72 | 45.67 | 44.36 | 44.13 | 53.52 | 59.11 | 54.18 | 56.04 | - |
| Inventory | 159.27M | 151.25M | 139.84M | 113.64M | 127.75M | 123.09M | 58.78M | 13.24M | 7.67M | 4.96M |
| Days Inventory Outstanding | 27.93 | 20.63 | 19.78 | 16.47 | 18.26 | 22.36 | 23.88 | 10.96 | 9.82 | 11.12 |
| Other Current Assets | 88.28M | 0 | 98.18M | 69.34M | 52.14M | 0 | 0 | 0 | -60.69M | 0 |
| Total Non-Current Assets | 3.74B | 3.59B | 3.73B | 3.86B | 4.63B | 4.58B | 1.45B | 365.12M | 253.02M | 190.79K |
| Property, Plant & Equipment | 795.08M | 674.22M | 618.36M | 637.53M | 622.01M | 546.34M | 110.47M | 63.56M | 61.6M | 35.57M |
| Fixed Asset Turnover | 4.20x | 4.81x | 5.27x | 5.02x | 4.78x | 4.49x | 9.56x | 8.33x | 5.61x | 5.41x |
| Goodwill | 2.57B | 2.54B | 2.68B | 2.72B | 3.55B | 3.51B | 998.81M | 266.79M | 202.44M | 38.63M |
| Intangible Assets | 80.23M | 85.12M | 105.55M | 130.16M | 162.77M | 202.23M | 116.06M | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -276.9M | 0 |
| Other Non-Current Assets | 18.8M | 19.12M | 17.58M | 21.13M | 22.41M | 15.1M | 16.48M | 6.85M | 253.02M | -74.01M |
| Total Assets | 4.42B | 4.32B | 4.49B | 4.51B | 5.22B | 5.25B | 1.81B | 546.54M | 254.12M | 310.62K |
| Asset Turnover | 0.65x | 0.75x | 0.73x | 0.71x | 0.57x | 0.47x | 0.58x | 0.97x | 1.36x | 619.93x |
| Asset Growth % | -9.58% | -3.8% | -0.48% | -13.62% | -0.59% | 189.53% | 231.81% | 115.07% | 81713% | - |
| Total Current Liabilities | 743.29M | 712.39M | 566.99M | 537M | 456.21M | 499.81M | 422.05M | 154.05M | 699.39K | 286.31K |
| Accounts Payable | 0 | 352.38M | 284.6M | 211.5M | 222.5M | 248.03M | 191.04M | 79.24M | 40.77K | 60.51K |
| Days Payables Outstanding | 47.43 | 48.06 | 40.27 | 30.65 | 31.81 | 45.06 | 77.6 | 65.63 | 0.05 | 0.14 |
| Short-Term Debt | 78.27M | 20.31M | 16.25M | 53.37M | 35M | 20M | 8.15M | 1.72M | 27.9M | 174.24K |
| Deferred Revenue (Current) | 116.14M | 0 | 34.94M | 38.57M | 31.64M | 31.37M | 11.04M | 9.56M | 7.51M | 0 |
| Other Current Liabilities | 665.01M | 291.27M | 33.55M | 14.68M | 19.86M | 43.19M | 126.37M | 20.3M | -27.9M | -9.95M |
| Current Ratio | 0.92x | 1.02x | 1.33x | 1.21x | 1.28x | 1.34x | 0.86x | 1.18x | 1.58x | 0.42x |
| Quick Ratio | 0.71x | 0.81x | 1.09x | 1.00x | 1.00x | 1.09x | 0.72x | 1.09x | -9.39x | -16.92x |
| Cash Conversion Cycle | 30.54 | 14.29 | 25.19 | 30.17 | 30.58 | 30.82 | 5.39 | -0.48 | 65.81 | - |
| Total Non-Current Liabilities | 2.17B | 2.08B | 2.34B | 2.5B | 2.61B | 2.68B | 1.11B | 458.27M | 7.88M | 54.91M |
| Long-Term Debt | 123.53M | 1.72B | 1.96B | 2.09B | 2.15B | 2.18B | 776.57M | 395.11M | 127.09M | 52.7M |
| Capital Lease Obligations | 315.64M | 118.07M | 104.91M | 108.28M | 108.34M | 120.18M | 0 | 233.14K | 172.47K | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.78M | 0 |
| Other Non-Current Liabilities | 2.04B | 243.8M | 272.02M | 302.09M | 344M | 380.25M | 334.01M | 62.92M | -119.39M | -52.7M |
| Total Liabilities | 2.91B | 2.79B | 2.91B | 3.04B | 3.06B | 3.18B | 1.53B | 612.32M | 8.57M | 286.31K |
| Total Debt | 201.81M | 1.9B | 2.13B | 2.29B | 2.33B | 2.37B | 807M | 416.82M | 155.17M | 174.24K |
| Net Debt | 153.84M | 1.8B | 2.02B | 2.22B | 2.28B | 2.22B | 707.03M | 339.94M | 154.22M | 54.42K |
| Debt / Equity | 0.13x | 1.25x | 1.35x | 1.56x | 1.08x | 1.15x | 2.87x | - | 0.62x | - |
| Debt / EBITDA | 0.40x | 3.18x | 3.39x | - | 3.79x | 4.90x | 5.25x | 4.53x | 3.14x | 0.01x |
| Net Debt / EBITDA | 0.31x | 3.00x | 3.21x | - | 3.72x | 4.59x | 4.60x | 3.70x | 3.12x | 0.00x |
| Interest Coverage | 0.65x | 0.86x | 2.07x | -4.54x | 1.89x | 3.01x | -3.97x | 0.44x | 7.29x | - |
| Total Equity | 1.51B | 1.53B | 1.58B | 1.47B | 2.16B | 2.07B | 280.85M | -65.78M | 248.42M | -34.07M |
| Equity Growth % | 6.35% | -3.28% | 7.6% | -32.03% | 4.41% | 635.88% | 526.93% | -126.48% | 829.18% | - |
| Book Value per Share | 11.15 | 11.29 | 11.64 | 10.91 | 15.52 | 15.54 | 5.35 | -0.91 | 7.95 | -1.09 |
| Total Shareholders' Equity | 1.51B | 1.52B | 1.57B | 1.46B | 2.15B | 2.06B | 354.89M | -38.82M | 245.55M | 24.31K |
| Common Stock | 14K | 13K | 13K | 13K | 13K | 13K | 9K | 7K | 240.55M | 719 |
| Retained Earnings | -649.01M | -632.97M | -562.18M | -652.6M | 26.3M | -43.02M | -199.2M | -40.26M | 2.09M | -693 |
| Treasury Stock | 0 | -25.55M | -25.55M | -43.27M | -13.99M | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 78K | 2.25M | 4.36M | 8.69M | -2.35M | -4.41M | 1.43M | 0 | 0 |
| Minority Interest | 7.41M | 7.76M | 6.97M | 8.21M | 6.6M | 4.78M | -74.04M | -26.96M | 2.87M | -34.09M |
High Debt Refinancing Risk
As reported in recent financial statements, AdaptHealth's debt structure underwent a significant shift in 2026Q1, with total debt plummeting from $1.9B to $201.8M, a development that warrants close scrutiny to determine if this reflects a permanent deleveraging event or a temporary accounting reclassification of liabilities.
The sudden reduction in reported debt levels suggests a potential change in capital structure strategy, yet the persistent negative retained earnings of $649.0M indicate that historical debt-fueled acquisitions have not yet generated sufficient equity value. Investors should monitor whether this deleveraging is sustainable or if it masks underlying liquidity constraints that could limit future operational flexibility.
Based on the company's balance sheet data, goodwill remains a dominant asset at $2.6B, representing over 59% of total assets as of 2026Q1, which suggests that the firm's valuation is heavily dependent on the successful integration of past acquisitions rather than tangible, income-generating medical equipment.
The high proportion of intangible assets relative to the $795.1M in net PPE implies that the company's competitive position is tied to acquired market share rather than proprietary physical infrastructure. This concentration creates a significant risk of impairment charges should the acquired business units fail to meet their projected cash flow targets in the current regulatory environment.
According to quarterly filings, the current ratio has tightened to 0.92 as of 2026Q1, indicating that the company's ability to cover short-term obligations with liquid assets has deteriorated compared to the 1.33 ratio observed in 2024Q1, signaling a potential narrowing of the firm's operational safety buffer.
The decline in the current ratio, coupled with a cash position of only $48.0M, suggests that the company may face challenges in managing its working capital requirements during periods of reimbursement delays. This liquidity profile appears increasingly fragile, necessitating a disciplined approach to cash management to avoid reliance on external financing for routine operations.
As evidenced by the company's reported figures, retained earnings have remained consistently negative, reaching -$649.0M in 2026Q1, which highlights a structural inability to build a sustainable equity base through organic profitability despite the company's extensive scale in the home medical equipment market.
The persistent deficit in retained earnings suggests that the capital allocation strategy has historically prioritized growth over the accumulation of shareholder value. This trend may indicate that the company's business model is currently optimized for market expansion rather than the generation of positive net income, leaving the equity base vulnerable to further erosion.
Quick answers to the most common questions about buying AHCO stock.
As of 2025, AdaptHealth Corp. (AHCO) had total assets of $4.32B including $728.9M in current assets.
AdaptHealth Corp. (AHCO) carries total debt of $1.90B, offset by $106.1M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
AdaptHealth Corp. (AHCO) has total shareholders' equity (book value) of $1.52B ($11.29 book value per share). Book value represents the net worth of the company belonging to common stock holders.
AdaptHealth Corp. (AHCO) reported a current ratio of 1.02x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.